BIOPHARMA BOSTON

CALL FOR PRESENTATIONS COMING IN JANUARY 2027!

ASAP BioPharma Boston

The Future of Alliances Starts Here

November 1-3, 2027
Renaissance Boston Seaport · Boston, MA
Boston, Massachusetts Boston, Massachusetts
128Companies
300+Attendees
70+Speakers
Menu

What to expect

Three days built by practitioners, for practitioners. Every session is chosen for its real-world relevance, which means you'll leave with strategies, frameworks, and connections you can actually use.

Sessions that reflect the work you do

The 2026 program covers what's actually changing the job: AI moving from experiment to daily toolkit, governance models stretching to handle three, four, or more partners at once, and alliance leaders being asked to own value realization, not just process. No product pitches. No purely theoretical topics. Just the real work our community comes for.

What you'll walk away with
  • Actionable strategies from 70+ alliance leaders and practitioners
  • High-value connections with peers from pharma, biotech, academia, and beyond
  • 12 professional development hours toward CA-AM or CSAP certification renewal
“Networking with peers who truly understand the art and science of alliances was game-changing. I connected with leaders across industries whose insights have reshaped how our teams think about collaboration and value creation.” ~ Kristin Rosner, PhD, CSAP, CA-AM, Senior Director, Global R&D Alliance Management, Takeda

2027 Conference Co-Chairs and 2026 Featured Speakers

Tracy Blois

Tracy Blois, PhD, Head of Alliance Management, Amgen

LinkedIn icon

Petra Sansom

Petra Sansom, PhD, CA-AM Vice President, Alliance Management, Beam Therapeutics

LinkedIn icon

Vivian Berlin

Vivian Berlin, PhD, Executive Director, Harvard Medical School, Harvard University

LinkedIn icon

Mark Bolton

Mark Bolton, Head of Global Government Affairs & Public Policy, Jazz Pharmaceuticals

LinkedIn icon

Chris Coburn

Chris Coburn, Chief Innovation Officer, Mass General Brigham


LinkedIn icon

Ed Cox

Ed Cox, Head of Forward Deployed Technology & Digital Health, Pfizer

LinkedIn icon

Aram Donigian

Aram Donigian, Clinical Professor of Business Administration, Faculty Director, Tuck Business Bridge Program, Dartmouth

LinkedIn icon

Aleksey Gerasyuto

Aleksey Gerasyuto, PhD,  Senior Vice President, Discovery & Preclinical Development Sciences, Schrödinger

LinkedIn icon

Andre Heeg

Andre Heeg, MD, Founder, The Upward ARC

LinkedIn icon

Dana Hughes

Dana Hughes, Partner, KPMG

LinkedIn icon

Alasdair Milton

Alasdair Milton, PhD, Partner & Principal, KPMG

LinkedIn icon

Roel ven den Akker

Roel van den Akker, Deals Partner, Pharmaceutical and Life Sciences, PwC

LinkedIn icon

Who's Attending

Join alliance and partnership leaders from more than 120 organizations across pharma, biotech, academia, and consulting.

  • AbbVie
  • AbCellera
  • Absci
  • AchieveUnite
  • ADARx
  • Ailux
  • allianceboard
  • Allorion Therapeutics
  • Alloy Therapeutics
  • Alnylam Pharmaceuticals
  • Alzheimer's Research UK UCL Drug Discovery Institute
  • Amgen
  • Argo Biopharmaceuticals
  • Arrowhead Pharmaceuticals
  • Astellas
  • AstraZeneca
  • Beam Therapeutics
  • BeOne Medicines
  • Biogen
  • BioNTech
  • Boehringer Ingelheim
  • Boston Children's Hospital
  • Boston Consulting Group
  • BridgeBio
  • Bristol Myers Squibb
  • C4 Therapeutics
  • Carberry Consulting
  • CAS
  • Chiesi Farmaceutici S.p.A.
  • Daiichi Sankyo
  • DNDi
  • Douglas Pharmaceuticals
  • Dyno Therapeutics
  • Eisai
  • Electrome
  • Eli Lilly and Company
  • EMD Serono
  • Enable Injections
  • Everest Medicines
  • Evopoint Biosciences
  • Flagship Pioneering
  • Foresight Diagnostics
  • Genevant Sciences
  • Genmab
  • Gilead Sciences
  • GondolaBio
  • GSK
  • Guardant Health
  • Harvard University
  • Houston Methodist Hospital
  • Illumina
  • IMMvention Therapeutix
  • Incyte
  • Inpart
  • Integrated Project Management (IPM)
  • Intercellular
  • Ionis Pharmaceuticals
  • Isomorphic Labs
  • Jazz Pharmaceuticals
  • Johnson & Johnson Innovative Medicine
  • Kailera Therapeutics
  • KDodd Consulting
  • KPMG
  • Kyorin Pharmaceutical
  • Kyowa Kirin
  • LifeArc
  • Lundbeck
  • Lygature
  • mAbxience
  • Mass General Brigham
  • Merck
  • Merck Sharp and Dohme (MSD)
  • Moderna
  • n-Lorem Foundation
  • Nabla Bio
  • Nationwide Children's Hospital
  • Novartis
  • Novo
  • NS Pharma
  • Nurix Therapeutics
  • Nutriquest
  • Ono Pharmaceutical
  • Oxford University
  • Partners4Patients Foundation
  • Pfizer
  • Pierre Fabre
  • Pillar Biosciences
  • PPAM Solutions
  • Precede BioSciences
  • Psivant Therapeutics
  • PwC
  • Quotient Therapeutics
  • SanegeneBio
  • Sanofi
  • Schrödinger
  • Servier
  • Shionogi
  • Simcere Pharmaceutical
  • Soufflé Therapeutics
  • Stanford University
  • Stealth Biotech
  • Sumitomo
  • Supernus
  • Symbix Consulting
  • Takeda Pharmaceuticals
  • Teva Pharmaceuticals
  • TFC BioSciences
  • The Broad Institute of MIT and Harvard
  • The Rhythm of Business
  • Thea Open Innovation
  • Tuck School of Business at Dartmouth College
  • University College London
  • University of Cambridge
  • University of Illinois - Chicago
  • University of Michigan
  • Upsher-Smith Laboratories
  • Valo Health
  • Vantage Partners
  • Voyager Therapeutics
  • Wave Life Sciences
  • X-Chem
  • Xencor
  • Xtalpi
  • Zealand Pharma

2026 Program

Sessions and times are subject to change

1:00-5:00 Board of Directors Meeting (Invite only)
6:00-8:00 Board of Directors Dinner (Invite only)
8:00-2:30

Alliance Essential Course  (separate registration and fee required)
Instructor: Christine Klatt, CSAP, CA-AM, Carberry Consulting

8:00-2:30 Applied Alliance Management Course formerly called the CA-AM Exam Prep (separate registration and fee required)
Instructor: Swati Prasad, PhD, CSAP CA-AM, Alloy Therapeutics
8:00-2:30 Alliance Strategy & Leadership Course (separate registration and fee required)
Instructor: Ann Trampas, CSAP, CA-AM, University of Illinois at Chicago
8:00-2:30

Mastering Alliance Management: Driving Clarity, Value, and Influence in Alliance Leadership Course (separate registration and fee required) Sponsored by Amgen

Instructors: Tracy Blois, PhD, Amgen, Vickie Dalton, PsyD, Clinical Psychologist, Katherine Kendrick, CSAP, CA-AM, Jazz Pharmaceuticals, Nick Palmer, Oaklin, and David Thompson, CSAP, CA-AM, BeOne Medicines

8:30-11:30      ASAP Advisory Council Meeting (w/ the Board of Directors) (Invite only)
11:30-2:30

Executive Leadership Luncheon & Forum (Invite only)
Andre Heeg, MD,
Upward ARC

12:00-2:00

Boston Dine Around Town

Kick off your BioPharma Boston experience with a casual lunch alongside a small group of fellow attendees. These intimate dine-arounds are a great way to connect and network before the conference begins.  An additional fee applies. Sign up under Networking Add-Ons in the conference registration.

DAY 1: ALLIANCE LEADERSHIP IN A CHANGING WORLD
3:00-3:15

BioPharma Boston Kick-Off, Nicole Boston, CAE, CA-AM, ASAP; Katherine Kendrick, CSAP, CA-AM, Jazz Pharmaceuticals; Arne Wörn, Novartis

3:15-3:45

101 - Extreme Negotiations
Aram Donigian, Tuck Business Bridge Program at Dartmouth
What do high-stakes negotiations in military operations have in common with the complex negotiations that shape today's business partnerships? More than most people realize. Drawing on his experience negotiating with tribal leaders, local officials, and assorted international partners while serving in the U.S. military, Aram explores the principles that determine success when the stakes are high, trust is fragile, and relationships must endure despite competing interests. In this keynote, Aram shares powerful stories from the field and translates them into practical lessons for leaders navigating strategic partnerships, cross-functional decision making, commercial negotiations, and organizational change. Participants will gain fresh perspectives on building trust under pressure, understanding interests beyond positions, using creativity to manage uncertainty, and creating influence without authority. Whether leading a critical alliance or negotiating a complex agreement, learn to succeed in the most challenging negotiation environments—where relationships matter as much as results. 

3:45-4:15

102 - The New Geography of BioPharma Innovation: China and the Changing Deal Landscape
Roel van den Akker, PwC
The geography of biopharma innovation is being redrawn. China’s biotech ecosystem has rapidly evolved into a major source of globally competitive science and innovative assets, increasing cross-border licensing, investment, and partnership activity. For global biopharma companies, this evolution creates both significant opportunity and new complexity. Deal structures are changing, competition for assets is increasing, and regulatory, geopolitical, valuation, and execution considerations are becoming more important. Drawing on PwC’s perspective across the global biopharma deal environment, Roel van den Akker will examine the forces driving China’s emergence as a global innovation hub and what they mean for the next generation of cross-border partnerships. The session will explore what alliance and business leaders should understand, and the capabilities they will need to build, when evaluating opportunities, structuring partnerships, managing risk, and preparing for the next phase of global biopharma collaboration.

4:15-4:30

Networking Break

4:30-5:15

103 - Leading Strategic Alliances in the AI Era
Brooke Paige, CSAP, CA-AM, Novartis, Tracy Blois, PhD, Amgen, Crystal Dillon, CA-AM , Eli Lilly, Fern McSorley, PhD, Isomorphic Labs & Petra Sansom, PhD, Beam Therapeutics 

Artificial intelligence is changing how organizations collaborate, make decisions, and manage strategic partnerships. For alliance leaders, AI now appears in the Alliance Management space in three ways: in how alliance teams work, within the partnerships they manage, and increasingly as the foundation of AI-centered alliances. Navigating all three requires new capabilities and a clear view of what technology cannot replace.

Focusing on the first of the three themes, four alliance leaders from large pharma, a mid-sized biotech, and an AI-first discovery company will share what they see in daily practice. Panelists will discuss how organizations are approaching AI adoption within alliance teams, how AI is changing the nature of collaboration with partners, and how alliance managers can address governance, data stewardship, and ethical use as these tools enter joint work.

5:15-5:45

104 - The External Forces No Alliance Can Ignore: How Policy, Pricing, & Geopolitics Are Reshaping Partnerships
Mark Bolton, Jazz Pharmaceuticals 

The potential implementation of Most-Favored-Nation (MFN) pricing policies in the United States represents a significant shift in how domestic drug valuation and international market structures intersect. This session examines the technical relationship between foreign reference pricing systems, proposed U.S. MFN models, and commercial biopharmaceutical economics. Using objective policy data, we will analyze how pricing agreements established in major global markets can influence domestic rebates, net sales calculations, and joint venture contractual terms. Attendees will review practical frameworks for mapping regulatory exposure, coordinating international data sharing, and incorporating policy analysis into standard alliance governance to support long-term business planning.

5:45-6:00

105 - Presentation of the Alliance Excellence Awards
Katherine Kendrick, CSAP, CA-AM, Jazz Pharmaceuticals, and Nicole Boston, CAE, CA-AM, ASAP

The ASAP Alliance Excellence Awards recognize outstanding achievement, leadership, and contributions within the alliance management community. These prestigious awards celebrate individuals who have demonstrated a commitment to advancing the profession and creating meaningful impact through strategic partnerships.

Award Categories:

  • Emerging Leader
  • Champion
  • Executive Leadership
  • Outstanding Service & Achievement
6:00-6:30

New Member  & First Timer  Reception
Join fellow new members and first-time attendees for an informal opportunity to meet ASAP volunteer leaders, ask questions, and start making connections before the Welcome Reception gets underway. It’s a great way to get to know the ASAP community and feel at home at the conference! 

6:00-8:00

Welcome and Awardee Celebration Reception (all invited) Sponsored by Jazz Pharmaceuticals

Join for an evening celebrating our Alliance Excellence Award winners! Enjoy live jazz, hors d’oeuvres, and a signature cocktail while connecting with fellow attendees. Guests can also participate in Find Your Groove, an optional interactive networking activity designed to spark conversations and build new connections.

“ASAP’s BioPharma Conference is unequivocally the most valuable event I attend each year. The rich content and community elevate my career and alliance capabilities."

Logistics

Venue & Room Block

Renaissance Boston Seaport District
606 Congress Street, Boston, MA 02210
Block opening soon

ASAP has secured discounted room rate of $289+ per/night (until October 9, 2027 or when the block is full). 

Justification Letter

To help secure approval for your participation, customize this letter.

"The ASAP BioPharma Conference is a transformative experience that brings together the brightest minds in the industry. The insights and connects are invaluable."

2026 Sponsors

We’re grateful to our sponsors whose support makes this event possible and strengthens the entire ASAP community. Their partnership enables us to deliver meaningful programs and experiences throughout the year. Interested in becoming an ASAP sponsor? Visit our sponsorship page to learn more and connect with us.

Platinum Level
Gold Level
Silver Level
Bronze Level